317 related articles for article (PubMed ID: 18690355)
1. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
2. Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia.
Semeraro N; Montemurro P; Giordano P; Schettini F; Santoro N; De Mattia D; Giordano D; Conese M; Colucci M
Thromb Haemost; 1990 Aug; 64(1):38-40. PubMed ID: 2274927
[TBL] [Abstract][Full Text] [Related]
3. [Changes in blood coagulation in treatment with ALL-BFM-90 and NHL-BFM-90 protocols].
Sutor AH; Niemeyer C; Sauter S; Witt I; Kaufmehl K; Rombach A; Brandis M; Riehm H
Klin Padiatr; 1992; 204(4):264-73. PubMed ID: 1518263
[TBL] [Abstract][Full Text] [Related]
4. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
Watanabe I; Sakai I; Matsumoto I
Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
[TBL] [Abstract][Full Text] [Related]
5. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Ito K; Matsuda T
Am J Hematol; 1989 Sep; 32(1):20-3. PubMed ID: 2757000
[TBL] [Abstract][Full Text] [Related]
6. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral thrombosis in a child with acute lymphocytic leukemia during L-asparaginase therapy].
Horigome Y; Hanada T; Inudoh M; Takita H
Rinsho Ketsueki; 1989 Aug; 30(8):1284-8. PubMed ID: 2601047
[TBL] [Abstract][Full Text] [Related]
8. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
[TBL] [Abstract][Full Text] [Related]
9. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children.
Legnani C; Palareti G; Pession A; Poggi M; Vecchi V; Bianchini B; Coccheri S
Haemostasis; 1988; 18(3):179-86. PubMed ID: 3181817
[TBL] [Abstract][Full Text] [Related]
10. Elimination of l-asparaginase in children treated for acute lymphoblastic leukemia.
Brueck M; Koerholz D; Nuernberger W; Juergens H; Goebel U; Wahn V
Dev Pharmacol Ther; 1989; 12(4):200-4. PubMed ID: 2504568
[TBL] [Abstract][Full Text] [Related]
11. [Acquired deficiencies in antithrombin III and C protein during treatment with L-asparaginase].
Mielot F; Danel P; Boyer C; Coulombel L; Dommergues JP; Tchernia G; Larrieu MJ
Arch Fr Pediatr; 1987 Mar; 44(3):161-5. PubMed ID: 2883953
[TBL] [Abstract][Full Text] [Related]
12. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
Koert M; Nowak-Göttl U; Kreuz W; Grüttner HP; Kornhuber B; Breddin HK
Klin Padiatr; 1991; 203(6):429-32. PubMed ID: 1721940
[TBL] [Abstract][Full Text] [Related]
13. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
Rodeghiero F; Castaman G; Dini E
Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923
[TBL] [Abstract][Full Text] [Related]
14. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
Zaunschirm A; Muntean W
Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215
[TBL] [Abstract][Full Text] [Related]
15. [13 parameters of coagulation and fibrinolysis--univariate pediatric normal values of hemostasis].
Nowak-Göttl U; Kreuz WD
Monatsschr Kinderheilkd; 1991 Jul; 139(7):403-8. PubMed ID: 1922117
[TBL] [Abstract][Full Text] [Related]
16. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
[TBL] [Abstract][Full Text] [Related]
17. Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.
Homans AC; Rybak ME; Baglini RL; Tiarks C; Steiner ME; Forman EN
J Clin Oncol; 1987 May; 5(5):811-7. PubMed ID: 3572467
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hormonal contraceptives on the coagulation system with special reference to its inhibitors].
Misz M; Beck P; Flóra-Nagy M
Orv Hetil; 1985 Oct; 126(43):2635-40. PubMed ID: 4058912
[TBL] [Abstract][Full Text] [Related]
19. Effects of single-dose L-asparaginase on coagulation values in healthy dogs and dogs with lymphoma.
Rogers KS; Barton CL; Benson PA; Green RA
Am J Vet Res; 1992 Apr; 53(4):580-4. PubMed ID: 1586032
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of coagulation and fibrinolysis parameters for diagnostics of disseminated intravascular blood coagulation (DIC).
Lezhen T; Kramarev S; Kolesnik L; Kudinov S
Mater Med Pol; 1992; 24(2):79-81. PubMed ID: 1307773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
